Olya Maximenko/ShutterstockWhile over 90% of people living with HIV in Europe have been tested for hepatitis C, diagnosis remains suboptimal in the east of the continent. In three of five European regions, fewer than 80% of people co-infected with HIV and hepatitis C have received hepatitis treatment and the proportion who have been cured does not exceed 80% in any region. The study published in the March issue of AIDS also shows that there are significant differences between countries.
A decade ago, the introduction of direct-acting antiviral agents that can cure hepatitis C in over 95% of patients turned its elimination into a realistic goal. In 2016, the World Health Organization (WHO) called for achieving this goal by 2030 with targets that included diagnosing 90% of all people with hepatitis C and treating 80% of those diagnosed with the virus. The WHO also recommended that treatment be prioritised for people with HIV and hepatitis C co-infection as they have a higher risk of rapid progression of liver fibrosis.
Read the full story at Aidsmap.
Source : Aidsmap
Related HIV and Co-Infections News
-
TheBodyPro: A new study on HIV, hypertension, and pregnancy is about a lot more than it seems
-
The Lancet Global Health: Untangling the complex relationship between HIV-exposure and TB in children: A narrative review
-
ACTG launches landmark study evaluating treatments for depressive disorders with or without mild neurocognitive disorder among people living with HIV
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.